X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (418) 418
index medicus (370) 370
vasculitis (250) 250
female (231) 231
male (215) 215
aged (192) 192
middle aged (189) 189
wegeners-granulomatosis (173) 173
rheumatology (167) 167
microscopic polyangiitis (160) 160
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (148) 148
anca-associated vasculitis (145) 145
adult (134) 134
anti-neutrophil cytoplasmic antibody-associated vasculitis - immunology (124) 124
anti-neutrophil cytoplasmic antibody-associated vasculitis - diagnosis (117) 117
immunosuppressive agents - therapeutic use (114) 114
anti-neutrophil cytoplasmic antibody-associated vasculitis - complications (113) 113
treatment outcome (113) 113
urology & nephrology (112) 112
cyclophosphamide (106) 106
retrospective studies (106) 106
antibody-associated vasculitis (103) 103
rituximab (99) 99
glomerulonephritis (92) 92
prognosis (86) 86
anti-neutrophil cytoplasmic antibody-associated vasculitis - therapy (84) 84
anti-neutrophil cytoplasmic antibody-associated vasculitis - mortality (81) 81
systemic vasculitis (80) 80
mortality (77) 77
randomized-trial (76) 76
antineutrophil cytoplasmic antibodies (75) 75
risk factors (74) 74
anca (73) 73
medicine & public health (68) 68
antibodies (67) 67
autoantibodies (64) 64
granulomatosis with polyangiitis (62) 62
antibodies, antineutrophil cytoplasmic - blood (61) 61
cyclophosphamide - therapeutic use (61) 61
remission induction (61) 61
renal vasculitis (61) 61
disease (60) 60
aged, 80 and over (59) 59
churg-strauss-syndrome (59) 59
small-vessel vasculitis (59) 59
therapy (59) 59
recurrence (57) 57
care and treatment (54) 54
adolescent (52) 52
antibodies, antineutrophil cytoplasmic - immunology (51) 51
nephrology (51) 51
anti-neutrophil cytoplasmic antibody-associated vasculitis - pathology (50) 50
viral antibodies (48) 48
anti-neutrophil cytoplasmic antibody-associated vasculitis - blood (47) 47
biopsy (47) 47
remission (47) 47
time factors (47) 47
anti-neutrophil cytoplasmic antibody-associated vasculitis - epidemiology (46) 46
survival rate (46) 46
severity of illness index (44) 44
young adult (44) 44
drug therapy, combination (43) 43
disease progression (42) 42
classification (40) 40
immunosuppressive agents - adverse effects (40) 40
medicine, general & internal (40) 40
peroxidase - immunology (40) 40
term-follow-up (40) 40
abridged index medicus (39) 39
neutrophils (39) 39
antibodies, monoclonal, murine-derived - therapeutic use (38) 38
diagnosis (38) 38
glucocorticoids - therapeutic use (37) 37
granulomatosis (37) 37
health aspects (37) 37
crescentic glomerulonephritis (36) 36
analysis (35) 35
immunology (35) 35
plasma exchange (35) 35
anti-neutrophil cytoplasmic antibody-associated vasculitis (34) 34
research (33) 33
animals (32) 32
polyarteritis-nodosa (32) 32
rapidly progressive glomerulonephritis (32) 32
relapse (32) 32
rheumatoid-arthritis (32) 32
anti-neutrophil cytoplasmic antibody (30) 30
antineutrophil cytoplasmic autoantibodies (30) 30
daily oral cyclophosphamide (30) 30
medical research (30) 30
patients (30) 30
epidemiology (29) 29
follow-up studies (29) 29
kidney - pathology (29) 29
kidney failure, chronic - etiology (29) 29
biomarkers - blood (28) 28
cohort studies (28) 28
kaplan-meier estimate (28) 28
kidney diseases (28) 28
maintenance therapy (28) 28
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 211 - 220
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2011, Volume 70, Issue 3, pp. 488 - 494
Journal Article
Kidney International, ISSN 0085-2538, 08/2013, Volume 84, Issue 2, pp. 397 - 402
Patients with antineutrophil cytoplasm antibody–associated vasculitis (AAV) requiring dialysis at diagnosis are at risk for developing end-stage renal disease... 
plasma exchange | vasculitis | randomized controlled trial | Plasma exchange | Randomized controlled trial | Vasculitis | UROLOGY & NEPHROLOGY | THERAPY | RENAL VASCULITIS | Kidney Failure, Chronic - mortality | Up-Regulation | Cyclophosphamide - administration & dosage | Glucocorticoids - administration & dosage | Plasma Exchange - mortality | Humans | Middle Aged | Male | Methylprednisolone - adverse effects | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - blood | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis | Time Factors | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Female | Plasma Exchange - adverse effects | Drug Therapy, Combination | Glucocorticoids - adverse effects | Immunosuppressive Agents - administration & dosage | Severity of Illness Index | Administration, Oral | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Disease Progression | Kidney Failure, Chronic - therapy | Administration, Intravenous | Creatinine - blood | Immunosuppressive Agents - adverse effects | Aged | Kidney Failure, Chronic - etiology | Methylprednisolone - administration & dosage | Renal Dialysis | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Urology and Nephrology
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2017, Volume 76, Issue 9, pp. 1566 - 1574
ObjectiveTo determine the magnitude of all-cause mortality risk in patients with antineutrophil cytoplasmic antibodies-associated vasculitis (AAV) compared... 
meta-analysis | mortality | observational studies | ANCA | vasculitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Observational Studies as Topic | Humans | Cause of Death | Studies | Vasculitis | Mortality | Bias | Antineutrophil cytoplasmic antibodies | Classification | Antibodies | Granulomatosis | Health risk assessment | Risk factors | Meta-analysis
Journal Article
Journal Article
Medicine (United States), ISSN 0025-7974, 2017, Volume 96, Issue 8, p. e6083
Journal Article
Medicine (United States), ISSN 0025-7974, 2016, Volume 95, Issue 37, p. e4871
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 10/2013, Volume 8, Issue 10, pp. 1709 - 1717
Journal Article
Journal Article